A congressional committee has asked the chief executive officer of Purdue Pharma and some members of the Sackler family that controls the company to testify at a hearing next month that will explore the role the drug maker played in fueling the opioid crisis in the U.S.
In a series of letters issued Wednesday, the House Committee on Oversight and Reform cited internal documents it released last month that helped to reinforce previous impressions — gleaned from years of litigation — about the way the drug maker was run by the secretive clan. The Dec. 8 hearing is an outgrowth of its investigation.
About the Author Reprints
